World Health Organization. World malaria report 2023. Geneva, Switzerland: World Health Organization; 2023.
Oladipo HJ, Tajudeen YA, Oladunjoye IO, Yusuff SI, Yusuf RO, Oluwaseyi EM, et al. Increasing challenges of malaria control in sub-Saharan Africa: Priorities for public health research and policymakers. Ann Med Surg. 2022. https://doi.org/10.1016/j.amsu.2022.104366.
Elnour Z, Grethe H, Siddig K, Munga S. Malaria control and elimination in Kenya: economy-wide benefits and regional disparities. Malar J. 2023;22:1–19. https://doi.org/10.1186/s12936-023-04505-6.
Alegana VA, Macharia PM, Muchiri S, Mumo E, Oyugi E, Kamau A, et al. Plasmodium falciparum parasite prevalence in East Africa: Updating data for malaria stratification. PLOS Glob Public Heal. 2021;1: e0000014. https://doi.org/10.1371/journal.pgph.0000014.
Githure JI, Yewhalaw D, Atieli H, Hemming-Schroeder E, Lee M-C, Wang X, et al. Enhancing malaria research, surveillance, and control in endemic areas of Kenya and Ethiopia. Am J Trop Med Hyg. 2022;107:14–20. https://doi.org/10.4269/ajtmh.21-1303.
Ndiaye YD, Hartl DL, McGregor D, Badiane A, Fall FB, Daniels RF, et al. Genetic surveillance for monitoring the impact of drug use on Plasmodium falciparum populations. Int J Parasitol Drugs Drug Resist. 2021;17:12–22. https://doi.org/10.1016/j.ijpddr.2021.07.004.
Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in Western Cambodia. N Engl J Med. 2008;359:2619–20. https://doi.org/10.1056/nejmc0805011.
Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50–5. https://doi.org/10.1038/nature12876.
Xie SC, Ralph SA, Tilley L. Artemisinin resistance. Trends Parasitol. 2020;36:533–44. https://doi.org/10.1016/j.pt.2020.03.006.
Chhibber-Goel J, Sharma A. Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance. Int J Parasitol Drugs Drug Resist. 2019;11:49–58. https://doi.org/10.1016/j.ijpddr.2019.10.001.
Rosenthal PJ, Asua V, Conrad MD. Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa. Nat Rev Microbiol. 2024;22(6):373–84. https://doi.org/10.1038/s41579-024-01008-2.
World Health Organization. Malaria: artemisinin partial resistance. 18 November 2022. https://www.who.int/news-room/questions-and-answers/item/artemisinin-resistance. Accessed 27 Aug 2024
Uwimana A, Umulisa N, Venkatesan M, Svigel SS, Zhou Z, Munyaneza T, et al. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. Lancet Infect Dis. 2021;21:1120–8. https://doi.org/10.1016/S1473-3099(21)00142-0.
Moser KA, Madebe RA, Aydemir O, Chiduo MG, Mandara CI, Rumisha SF, et al. Describing the current status of Plasmodium falciparum population structure and drug resistance within mainland Tanzania using molecular inversion probes. Mol Ecol. 2021;30:100–13. https://doi.org/10.1111/mec.15706.
Juliano JJ, Giesbrecht DJ, Simkin A, Fola AA, Lyimo BM, Pereus D, et al. Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania. MedRxiv. 2023. https://doi.org/10.1101/2023.11.07.23298207.
Mesia Kahunu G, Wellmann Thomsen S, Wellmann Thomsen L, Muhindo Mavoko H, Mitashi Mulopo P, Filtenborg Hocke E, et al. Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo. Int J Infect Dis. 2024;139:41–9. https://doi.org/10.1016/j.ijid.2023.11.026.
Mihreteab S, Platon L, Berhane A, Stokes BH, Warsame M, Campagne P, et al. Increasing prevalence of artemisinin-resistant HRP2-negative malaria in Eritrea. N Engl J Med. 2023;389:1191–202. https://doi.org/10.1056/nejmoa2210956.
Fola AA, Feleke SM, Mohammed H, Brhane BG, Hennelly CM, Assefa A, et al. Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia. Nat Microbiol. 2023. https://doi.org/10.1038/s41564-023-01461-4.
Balikagala B, Fukuda N, Ikeda M, Katuro Osbert T, Tachibana SI, Yamauchi M, et al. Evidence of artemisinin-resistant malaria in Africa. N Engl J Med. 2022. https://doi.org/10.1056/nejmc2117480.
Maniga JN, Samuel M, John O, Rael M, Muchiri JN, Bwogo P, et al. Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment. Malar J. 2023;22:1–13. https://doi.org/10.1186/s12936-023-04517-2.
Jeang B, Zhong D, Lee MC, Atieli H, Yewhalaw D, Yan G. Molecular surveillance of Kelch 13 polymorphisms in Plasmodium falciparum isolates from Kenya and Ethiopia. Malar J. 2024;23:1–11. https://doi.org/10.1186/s12936-023-04812-y.
Wamae K, Okanda D, Ndwiga L, Osoti V, Kimenyi KM, Abdi AI, et al. No evidence of P. falciparum K13 artemisinin conferring mutations over a 24-year analysis in Coastal Kenya, but a near complete reversion to chloroquine wild type parasites. Antimicrob Agents Chemother. 2019. https://doi.org/10.1128/AAC.01067-19.
Osborne A, Phelan JE, Kaneko A, Kagaya W, Chan C, Ngara M, et al. Drug resistance profiling of asymptomatic and low-density Plasmodium falciparum malaria infections on Ngodhe island, Kenya, using custom dual-indexing next-generation sequencing. Sci Rep. 2023;13:1–10. https://doi.org/10.1038/s41598-023-38481-3.
Conrad MD, Asua V, Garg S, Giesbrecht D, Niaré K, Smith S, et al. Evolution of partial resistance to artemisinins in malaria parasites in Uganda. N Engl J Med. 2023;389:722–32. https://doi.org/10.1056/nejmoa2211803.
Atsiaya GO, Gido EO, Sibiko KW. Uptake of climate-smart agricultural practices among smallholder sorghum farmers in Busia County, Kenya. Cogent Food Agric. 2023;9(1):2204019. https://doi.org/10.1080/23311932.2023.2204019.
Division of National Malaria Programme (DNMP) [Kenya] and ICF. 2021. Kenya Malaria Indicator Survey 2020. Nairobi, Kenya and Rockville, Maryland, USA: DNMP and ICF.
Jaturas N, Onnoi N, Kumar T, Guo Jie BM, Onichandran S, Ponnampalavanar S, et al. A reproducible method for extraction of Plasmodium falciparum DNA by microwave irradiation and its potential for rapid molecular diagnosis. Trop Biomed. 2015;32:753–60.
Edgar RC. MUSCLE: Multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–7. https://doi.org/10.1093/nar/gkh340.
Ye R, Hu D, Zhang Y, Huang Y, Sun X, Wang J, et al. Distinctive origin of artemisinin-resistant Plasmodium falciparum on the China-Myanmar border. Sci Rep. 2016;6:20100. https://doi.org/10.1038/srep20100.
Beshir KB, Sutherland CJ, Sawa P, Drakeley CJ, Okell L, Mweresa CK, et al. Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. J Infect Dis. 2013;208:2017–24. https://doi.org/10.1093/infdis/jit431.
White NJ. Malaria parasite clearance. Malar J. 2017;16:1–14. https://doi.org/10.1186/s12936-017-1731-1.
Newton PN, Angus BJ, Chierakul W, Dondorp A, Ruangveerayuth R, Silamut K, Teerapong P, Suputtamongkol Y, Looareesuwan S, White NJ. Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria. Clin Infect Dis. 2003;37(1):7–16. https://doi.org/10.1086/375059.
Add Comment